A Phase I, Single Center, Randomized, Open-Label, Study Investigating the Effect of Food, Rabeprazole, Methotrexate and Formulation on the Pharmacokinetics of GDC-0853 and the Effect of GDC-0853 on the Pharmacokinetics of Methotrexate in Healthy Subjects
Phase of Trial: Phase I
Latest Information Update: 04 Apr 2017
At a glance
- Drugs GDC 0853 (Primary) ; Folic acid; Methotrexate; Rabeprazole
- Indications Autoimmune disorders
- Focus Pharmacokinetics
- Sponsors Genentech
- 01 Nov 2016 Status changed from recruiting to completed.
- 04 May 2016 Planned End Date changed from 1 Apr 2016 to 1 May 2016.
- 04 May 2016 Planned primary completion date changed from 1 Apr 2016 to 1 May 2016.